The effect of Kineret ® on
brain biomarkers in patients with subarachnoid haemorrhage

This trial has now closed

Primary objective

To determine whether IV administered Kineret ® inhibits the central nervous system (CNS) inflammatory response in patients with SAH

Study design

Double blinded randomised controlled trial

Inclusion criteria

Exclusion criteria

Further details

Brain Injury Research Team
CSB, Salford Royal Foundation Hospital NHS Trust
Stott Lane
Salford
M6 8HD
Tel: 0161 206 5755
Fax: 0161 707 6534
Email: misah@manchester.ac.uk


Randomisation service provided by: Sealed Envelope™.com